Cadence Design Systems (CDNS) - Company Research
Last Updated: 30 April 2026
Cadence Design Systems, Inc. (NASDAQ: CDNS) is one of the two dominant suppliers of electronic design automation (EDA) software, semiconductor IP, hardware emulation/prototyping systems and system-design tools that the global chip industry uses to design and verify integrated circuits. With Synopsys, Cadence sits inside the entrenched EDA duopoly — estimated combined ~60% of the global EDA market — that every major fabless designer and IDM relies on to put advanced silicon into production. Q1 2026 (reported 27 April 2026) delivered record revenue of $1.474 bn (+19% YoY), a record backlog of $8.0 bn, non-GAAP operating margin of 44.7%, and non-GAAP EPS of $1.96. Management raised FY26 revenue guidance to $6.125–$6.225 bn (+16–18% YoY) on the back of accelerating AI-driven design activity, expanded TSMC alliance work for the N3/N2/A16/A14 nodes, and a deeper agentic-AI collaboration with NVIDIA and Google Cloud. The shares closed at $325.33 on 28 April 2026 (market cap ~$89 bn) after a 3.3% post-earnings dip despite the raised outlook. This report walks through every material angle — without analyst opinions or price targets. For live pricing see our live charts, upcoming releases on the economic calendar, and discussion on the ChartsView forum.
1. Company Snapshot
| Company | Cadence Design Systems, Inc. |
| Ticker | NASDAQ: CDNS (Nasdaq-100, S&P 500) |
| Sector / Industry | Technology — Electronic Design Automation (EDA), Semiconductor IP, System Design & Analysis |
| HQ | 2655 Seely Avenue, San Jose, California 95134, USA |
| President & CEO | Anirudh Devgan (President since 2017, CEO since 15 December 2021) |
| Executive Chair | Lip-Bu Tan (former CEO, now Executive Chair; also CEO of Intel since March 2025) |
| CFO | John Wall (Senior VP & CFO) |
| Founded | 1988 via the merger of SDA Systems (founded 1983) and ECAD, Inc. (founded 1982) |
| Employees | ~13,800 worldwide (FY25) |
| Fiscal year end | 31 December |
| Share price (28 Apr 2026) | $325.33 (closing); 52-week range $262.75 — $376.45 |
| Market cap (28 Apr 2026) | ~$89 bn (~274 m diluted shares) |
| FY2025 revenue | $5.297 bn (+14% YoY) |
| FY2025 non-GAAP operating margin | 44.6% |
| Q1 2026 revenue | $1.474 bn (+19% YoY) |
| Q1 2026 backlog | $8.0 bn (record) |
| FY2026 revenue guidance | $6.125–$6.225 bn (16–18% growth) |
| FY2026 non-GAAP EPS guidance | $7.85–$7.95 |
| Dividend | None — capital return via buybacks |
| Website | cadence.com / investor.cadence.com |
2. Bull Case vs Bear Case
| Bull Case | Bear Case |
|---|---|
| EDA duopoly with Synopsys: combined ~60% of global EDA, with Cadence at ~30% share. Switching costs are extreme — design teams build years of methodology, scripts and IP libraries around a vendor's flow. | Premium valuation: trailing P/E ~68×, forward P/E ~35×, EV/EBITDA ~31–40×. Any deceleration would compress the multiple sharply. |
| Q1 2026 record results: revenue $1.474 bn (+19% YoY), backlog $8.0 bn (record), non-GAAP operating margin 44.7%, every segment up double-digits. | FY26 non-GAAP EPS guidance was trimmed slightly relative to prior expectations to absorb costs from a recent acquisition; the stock fell 3.3% on 28 April despite the revenue raise. |
| FY26 revenue outlook raised to 17% growth (mid-point) — management targets the "Rule of 60" for the first time (revenue growth + non-GAAP operating margin). | Export-control / China exposure: U.S. licensing rules around advanced EDA tools to Chinese fabless customers remain a watchpoint; any tightening could remove a slice of forward bookings. |
| IP business +25% in 2025; System Design & Analysis +18% in 2025; Hardware (Palladium / Protium emulation) added 30+ new customers and broke records on AI / HPC demand. | Hardware revenue is lumpy — Palladium / Protium capex by hyperscalers and fabless leaders drives quarterly variance; a hyperscaler pause would be visible in the print. |
| Strategic alliances: April 2026 expansion of TSMC partnership covers N3, N2, A16, A14 nodes; deeper agentic-AI collaboration with NVIDIA and a fresh Google Cloud collaboration around the ChipStack super-agent. | Concentration risk: top customers are the same handful of fabless leaders, IDMs and hyperscalers driving every other semiconductor capex story; a broad capex pause would compress core EDA renewals. |
| Insider transactions remain modest and pre-planned: CEO Devgan sold 20,000 shares on 5 December 2025 at ~$340 ($6.8 m, 10b5-1) but still holds ~196,000 shares plus large unvested PSUs. | Lip-Bu Tan, long-time former CEO and architect of the modern Cadence, is now CEO of customer-and-rival Intel since March 2025; while remaining Executive Chair, his attention is elsewhere. |
3. What Does This Company Actually Do?
Cadence sells the software, IP and hardware systems chip designers use to put silicon into production. Designs that begin in PowerPoint at a hyperscaler or fabless leader end up — tens of thousands of engineering hours later — as a working chip largely because Cadence's tools (and Synopsys's) automate the otherwise impossible task of placing, routing, simulating and verifying billions of transistors. FY25 revenue mix (estimated, % of $5.297 bn):
| Segment | What it sells | FY25 revenue mix |
|---|---|---|
| Core EDA | Digital implementation (Innovus, Genus, Tempus), custom/analog (Virtuoso, Spectre), verification (Xcelium, JasperGold). The flagship recurring software franchise. | ~67% |
| IP | Silicon-proven IP blocks — high-speed interconnect (DDR, PCIe, CXL, UCIe), Tensilica processors, AI-accelerator IP. Sold per design / per royalty. | ~16% |
| Hardware (Systems) | Palladium emulation systems and Protium prototyping platforms — used by hyperscalers and fabless leaders to verify SoCs pre-silicon. | ~10% |
| System Design & Analysis (SDA) | Multi-physics simulation (Allegro PCB, Sigrity, Celsius, Clarity, Fidelity) — thermal, EM, CFD for chips, packages and full systems. | ~7% |
Recurring software (Core EDA + much of SDA) is the financial engine: high-80s% gross margins, multi-year subscriptions, near-zero churn at the tier-1 customer level. The IP business attaches naturally on top of the EDA flow — a customer that builds chips in Cadence's tools is the natural buyer of Cadence's interconnect or AI IP.
4. The Business Model
How they make money. Core EDA is a multi-year subscription — customers pay an annual fee (often six- to nine-figures at the largest accounts) for time-based access to the toolset. Renewals at the tier-1 fabless and IDM level are effectively automatic; switching cost is years and tens of millions of dollars of methodology investment. IP is sold per design (a one-time licence to use a block in a specific chip) plus royalties per chip shipped — so success-of-the-customer flows back as recurring royalty. Hardware is large up-front systems sales (Palladium boxes regularly run multiple millions of dollars per unit) plus maintenance.
Margins and profile. FY25 GAAP gross margin was ~88–90% (software-style); FY25 non-GAAP operating margin was 44.6%, with management targeting the Rule of 60 (revenue growth % + non-GAAP operating margin %) for the first time in 2026. Free cash flow in FY25 exceeded $1.7 bn. Capital allocation prioritises tuck-in M&A (BETA CAE, Pulsic, Future Facilities, Invecas, Beecube, plus the recent acquisition referenced in Q1 2026 EPS guidance) and share buybacks; Cadence has never paid a dividend.
Moat. Three reinforcing layers: (i) tool stickiness — design methodologies are built around a specific tool flow over 10+ years; (ii) customer-specific PDK/foundry collateral — each new TSMC, Samsung Foundry or Intel Foundry node requires Cadence-specific certification, locking in the relationship; (iii) IP attach — once the EDA seat exists, Cadence IP is the path-of-least-resistance choice. Together these explain how two vendors share ~60% of EDA with effectively zero churn at the top of the pyramid.
Subsidy / regulatory dependency. Direct subsidy or tax-credit dependency is minimal — Cadence is not a chip fab and does not consume CHIPS Act capex grants. The relevant regulatory exposure is in the opposite direction: U.S. export-control licensing on advanced-node EDA tools sold to Chinese customers is a constraint, not a benefit, and management has spoken to this on multiple calls.
5. Financial Health
Five-year revenue and non-GAAP operating margin trajectory:
| Year | Revenue ($bn) | YoY growth | Non-GAAP op. margin | Notes |
|---|---|---|---|---|
| FY2021 | $2.99 | +14% | ~37% | Devgan named CEO, Dec 2021 |
| FY2022 | $3.56 | +19% | ~40% | Hardware acceleration |
| FY2023 | $4.09 | +15% | ~42% | IP +20%; record bookings |
| FY2024 | $4.64 | +13% | ~43% | Core EDA 71% of mix |
| FY2025 | $5.297 | +14% | 44.6% | Q4 record; BETA CAE / IP M&A |
| FY2026 guide (raised) | $6.125–$6.225 | +16–18% | ~44.5–45.5% | Rule of 60 target |
Quarterly revenue and gross margin (last 5 quarters; gross margin is software-heavy, ~88–90% range):
| Quarter | Revenue ($bn) | YoY growth | Non-GAAP op. margin | GAAP gross margin (approx) |
|---|---|---|---|---|
| Q1 2025 | $1.242 | +23% | 43.5% | ~89% |
| Q2 2025 | $1.275 | +20% | 44.0% | ~89% |
| Q3 2025 | $1.339 | +11% | 45.0% | ~90.7% |
| Q4 2025 | $1.440 | +6% | 45.8% | ~89% |
| Q1 2026 | $1.474 | +19% | 44.7% | ~89% |
Cash, debt, share count. End-FY25 cash & investments approached $3 bn against modest senior-notes debt. Diluted shares outstanding ~274 m (down low-single-digits from 280 m+ five years ago after sustained buybacks). Free cash flow in FY25 was ~$1.75 bn; the bulk has been redeployed into M&A and buybacks rather than dividends.
6. Valuation & Market Data
Raw market data (sourced 28–30 April 2026; figures vary intraday):
| Metric | Value | Notes |
|---|---|---|
| Share price (28 Apr 2026) | $325.33 | -3.3% post-Q1 print despite revenue raise |
| Market cap | ~$89 bn | ~274 m diluted shares |
| Enterprise value | ~$87 bn | Net cash position modest |
| 52-week high | $376.45 | Reached early 2026 |
| 52-week low | $262.75 | Post-Aug 2025 reset |
| Trailing P/E (GAAP) | ~68× | Yahoo / stockanalysis.com |
| Forward P/E (FY26 guide non-GAAP) | ~41× | Mid-point $7.90 EPS |
| P/S (FY25) | ~16.8× | $5.297 bn revenue |
| EV/EBITDA (TTM) | ~31–40× | Source range |
| FCF yield (FY25) | ~2.0% | ~$1.75 bn FCF / ~$89 bn cap |
| Dividend yield | 0% | No dividend |
| Short interest | ~5.91 m shares (~2.2% float) | Down ~18% MoM (Apr 2026) |
| Days to cover | ~2 days | vs. ~3 m daily volume |
7. What Are They Building / What's Coming?
Agentic AI for chip design. Cadence's "ChipStack" and the new "Super Agents" — VitaStack (verification) and InnoStack (digital implementation), unveiled in April 2026 — are designed to let large language models orchestrate Cadence's tools across design phases rather than running them point-tool by point-tool. Pricing is consumption-based, which management has flagged as a future EDA monetisation lever.
TSMC alliance — expanded April 2026. Long-running collaboration extended to cover end-to-end certified flows for the N3, N2, A16 (Angstrom-class) and A14 process nodes, including TSMC-specific reference flows for AI/HPC, 3D-IC and chiplet packaging. Each node certification is a multi-quarter engagement that locks the foundry's customers into the certified flow.
Google Cloud — April 2026. Strategic collaboration to optimise Cadence ChipStack on Google Cloud (TPUs and Axion CPUs), targeting cloud-native chip design with elastic compute. Joins existing AWS and Azure availability of Cadence Cloud.
NVIDIA — deepening agent-based collaboration. Joint reference designs around using NVIDIA's stack for AI-assisted chip-design tasks, including code generation and verification orchestration; NVIDIA's own silicon designs run on Cadence flows.
Hardware roadmap. Palladium Z3 (announced 2024) continues to ramp; Protium X3 prototyping system addresses the multi-billion-gate emulation requirement at AI/HPC customers. Hardware grew "another record year" in 2025 with 30+ new logo wins.
IP. The IP business grew ~25% in FY25 driven by interconnect IP (UCIe / chiplets, PCIe Gen 6/7, DDR5/HBM), Tensilica AI accelerators, and design-IP wins at hyperscalers building custom silicon. UCIe IP is positioned as a chiplet-era enabler.
Recent M&A. Beyond the BETA CAE acquisition (system-level multi-physics, completed 2024), Cadence has continued tuck-in deals; the FY26 EPS guidance reflects costs from a recent acquisition referenced on the Q1 2026 call.
CadenceLIVE 2026. Annual user / customer conference scheduled for 2026; historically a venue for major product announcements (Palladium generations, super-agents).
8. Competitive Landscape
EDA is one of the most concentrated software markets in the world. Three vendors share >90% of revenue, with Cadence and Synopsys jointly dominant:
| Competitor | Estimated EDA share (2025) | Strengths | Weaknesses vs Cadence |
|---|---|---|---|
| Synopsys (SNPS) | ~31% | Verification (VCS), digital implementation, broad IP portfolio, recent Ansys acquisition (closed 2025) | IP integration vs Cadence's tighter custom/analog flow |
| Cadence Design Systems (CDNS) | ~30% | Custom/analog (Virtuoso unmatched), digital implementation, Palladium emulation, IP, system design (BETA CAE, Sigrity) | Smaller pure-play services footprint than Synopsys |
| Siemens EDA (formerly Mentor) | ~13% | Calibre signoff (DRC/LVS de facto standard at most foundries), PCB tools, IC packaging | Smaller verification and IP businesses; private inside Siemens |
| Ansys | ~3% (now part of Synopsys) | Multi-physics simulation (mechanical, EM, fluid) | Acquired by Synopsys in 2025 — reshapes the system-design battlefield |
| Keysight EDA / PathWave | ~2% | RF / 5G / 6G simulation | Niche; not a full-flow vendor |
| Empyrean / Primarius (CN) | ~1–2% | Domestic Chinese alternative pushed by export-control reality | Sub-scale; cannot match Cadence/Synopsys at advanced nodes |
The competitive picture changed materially in 2025: Synopsys closed its Ansys acquisition, expanding its multi-physics footprint and reshaping the competitive comparison in system-level simulation. Cadence's response is the BETA CAE / Future Facilities / Pulsic-stack of system-design assets and the System Design & Analysis segment that grew 18% in 2025. The duopoly itself looks robust — Empyrean's growth in China is real but sub-scale, and the other smaller vendors (Aldec, Verific, Pulsic-pre-acquisition) compete in narrow slivers rather than the full flow.
9. Leadership and Ownership
CEO — Anirudh Devgan. President and CEO since 15 December 2021; with Cadence since 2012; PhD in electrical and computer engineering from Carnegie Mellon. Previously SVP and General Manager of the Digital & Signoff Group, the segment that built much of the modern Innovus / Tempus stack. Devgan succeeded Lip-Bu Tan, who remains Executive Chair (Tan is now also CEO of Intel since March 2025).
CFO. John Wall, Senior VP & Chief Financial Officer, with a long Cadence career and a frequent voice on the calls.
Board. Lip-Bu Tan (Executive Chair), James S. Miller, Ita M. Brennan, Mary Louise Krakauer, Young K. Sohn, Alberto Sangiovanni-Vincentelli (co-founder, professor emeritus UC Berkeley), Julia Liuson, John A.C. Swainson and others.
Insider transactions (recent and material).
| Date | Insider | Action | Shares | Price | Value | Plan |
|---|---|---|---|---|---|---|
| 5 Dec 2025 | Anirudh Devgan (CEO) | Sell | 20,000 | ~$340 | ~$6.8 m | 10b5-1 (pre-planned) |
| 2025 (multiple) | Anirudh Devgan (CEO) | PSU vest / withhold for tax | 146,849 acquired (PSU); plus 43,318 PSU vesting in three tranches | $0 (equity comp) | n/a | Performance-based compensation |
| 2024 (multiple) | CEO & other officers | Sell (multiple tranches) | 25,550 (sum) | various | ~$8.6 m | 10b5-1 plans |
Pattern: insider activity at Cadence is overwhelmingly compensation-driven and 10b5-1-planned, not opportunistic. Devgan's residual stake remains material at ~196,000 common shares plus large unvested PSUs.
Institutional ownership. Roughly 88% of shares are held by institutions. Top holders:
| Holder | Shares | % of shares out | Recent activity |
|---|---|---|---|
| The Vanguard Group | ~26.80 m | ~9.84% | Added 324,805 (+1.23%) |
| BlackRock Inc. | ~15.73 m | ~5.78% | Trimmed 134,445 (-0.85%) |
| State Street Corp | ~10–11 m | ~4% | Stable |
| Fidelity / FMR | ~7–9 m | ~3% | Adding |
| Geode Capital | ~6 m | ~2% | Adding |
10. Risks and Challenges
- Valuation risk. Trailing P/E ~68×, forward P/E mid-30s to low-40s, EV/EBITDA in the 30s. Premium multiples assume continued mid-teens growth and margin expansion; any deceleration would compress quickly.
- Export-control / China. U.S. licensing rules on advanced-node EDA tools to Chinese customers are a moving target. Tightening rules would remove a slice of forward bookings; loosening (less likely under the current regime) would help. Empyrean's growth is partly a function of Chinese customers being unable to renew at the leading nodes with U.S. EDA.
- Customer concentration. Top customers are NVIDIA, AMD, Qualcomm, Apple, Intel, Samsung, TSMC, plus the major hyperscalers' custom-silicon programmes. A capex pause or design-cycle slip at the top accounts shows up in the print.
- Hardware lumpiness. Palladium / Protium revenue is large-deal driven; Q-on-Q variance can be material. Q4 2025 hardware was a record; this is a tailwind today but creates tougher comps in 2026.
- Competitive geometry shift. Synopsys-Ansys creates a stronger combined offering in system-level multi-physics. Cadence's BETA CAE / Sigrity / Future Facilities response is real but has to keep pace.
- EPS guide haircut. Despite the revenue raise, Q1 2026 saw a slight non-GAAP EPS guide trim attributable to recent-acquisition costs. Market reaction (-3.3% on 28 April) suggests the print was priced as "good revenue, modestly worse profit per share than hoped".
- Regulatory / governance. Lip-Bu Tan's dual role (Executive Chair of Cadence + CEO of Intel since March 2025) creates an ongoing related-party watchpoint — Intel is both a Cadence customer and (via Intel Foundry) a partner. Cadence has disclosed and managed conflicts of interest, but the relationship will continue to draw governance scrutiny.
- Macro / capex cycle. Semiconductor capex moves with end-demand and inventory cycles. A sharp downcycle in fabless and IDM design starts would slow new-licence growth (renewals are stickier).
- AI commoditisation of design. The same agentic-AI capabilities Cadence is building could, in theory, lower the moat by reducing the number of design hours per chip. Management's bet is that consumption-based pricing offsets that — less time per design but more designs — but the slope is unproven.
- Capital allocation. Cadence has tilted to M&A + buyback. Goodwill on the balance sheet is significant after a decade of bolt-ons; an acquisition that doesn't deliver creates an impairment risk.
11. Recent Developments
Last 48 hours (28–30 April 2026)
- 28–29 April: Stock fell 3.3% to $325.33 the day after the Q1 2026 print despite the raised revenue outlook, then traded sideways. Multiple sell-side firms raised price targets. Short interest sits at ~5.91 m shares (~2.2% of float), down ~18% MoM.
- 29 April: Routine 13F-driven institutional flow notices — Sanctuary Advisors trimmed 2,312 shares (Daily Political); M&T Bank Corp disclosed $5.28 m holding earlier in the week.
Last 6 months
- 27 April 2026 — Q1 2026 results. Revenue $1.474 bn (+19% YoY), GAAP EPS $1.23, non-GAAP EPS $1.96, non-GAAP operating margin 44.7%. Backlog record $8.0 bn ($4.0 bn expected within 12 months). FY26 revenue guidance raised to $6.125–$6.225 bn (16–18% growth); non-GAAP EPS guide $7.85–$7.95. Q2 2026 guide: revenue $1.555–$1.595 bn; non-GAAP EPS $2.02–$2.08.
- April 2026 — AI Super Agents (VitaStack, InnoStack). Launched as part of the broader ChipStack agentic-AI platform.
- April 2026 — expanded TSMC alliance. Certified end-to-end EDA flows extended to N3, N2, A16 and A14 nodes plus 3D-IC packaging reference flows.
- April 2026 — Google Cloud collaboration. ChipStack agent optimised on Google Cloud infrastructure (TPUs + Axion CPUs).
- 5 February 2026 — Q4 2025 results. Revenue $1.440 bn (+6% YoY), FY25 revenue $5.297 bn (+14%), FY25 non-GAAP operating margin 44.6%. Beginning 2026 with a $7.8 bn backlog.
- 5 December 2025 — CEO 10b5-1 sale. Anirudh Devgan sold 20,000 shares at ~$340 ($6.8 m).
- 27 October 2025 — Q3 2025 results. Revenue $1.339 bn; backlog $7.0 bn; FY25 revenue guide raised to ~14% growth.
- Throughout 2025 — AI portfolio rollout. Cerebrus AI Studio (digital), Verisium AI (verification), Optimality AI (system optimisation) and Allegro X AI (PCB) all reached production-grade adoption at major customers.
- March 2025 — Lip-Bu Tan named CEO of Intel. Tan remains Executive Chair of Cadence; the appointment was a major industry event given Tan's Cadence legacy.
12. Key Dates Coming Up
| Date | Event | Notes |
|---|---|---|
| Late July 2026 (est.) | Q2 2026 results | Guide: revenue $1.555–$1.595 bn; non-GAAP EPS $2.02–$2.08 |
| Q3 2026 (est. late Oct 2026) | Q3 2026 results | Will test the agentic-AI consumption thesis |
| 2026 | CadenceLIVE 2026 | Annual customer conference; historically launches major product generations |
| Throughout 2026 | TSMC node certifications | Sequential go-live on N2 and A16 reference flows |
| Throughout 2026 | U.S. export-control updates | BIS / Commerce Department licensing decisions on advanced-node EDA |
| Q4 2026 / early 2027 | FY26 full-year results | Test of the Rule-of-60 target |
Related on ChartsView: Live charts & technicals · Economic calendar · ChartsView forum · Blog
Disclaimer: This report is compiled from primary sources (company filings, earnings transcripts, press releases, regulatory filings) and is for information only. It does not contain analyst price targets, ratings or buy / sell / hold recommendations and is not investment advice. Always do your own research. ChartsView and the author may or may not hold positions in any securities mentioned.
Loading research report…
13. Thesis Verdict
The central thesis. The report describes a consistent upward trend over the last five years with peer-comparable positioning on structural metrics. No near-term catalyst sits inside the next month; the thesis is tested over the medium term. The bull case and bear case presented by the report carry broadly comparable weight on the evidence compiled here.
What would confirm or break it. Recent news flow has been broadly mixed with a limited number of high-severity risks disclosed. Subsequent earnings landing in line with or above management guidance would reinforce the thesis; materialisation of the top disclosed risk — or any filing that fundamentally alters the growth or capital-return profile — would invalidate it. The deterministic rule engine classifies this evidence base as moderate.
Watchpoints
- InvalidatesMaterialisation of the "Capital allocation." risk, or any disclosure that fundamentally alters the capital-return or growth profile stated by management.
- ConfirmsSubsequent earnings and filings reinforcing the figures presented in this report.
- InvalidatesAny disclosure that directly contradicts a material claim in the bull case.
Diagnostic grid
Generated by ChartsView research tooling (rule-derived summary — LLM unavailable). Thesis strength measures how well the evidence in this report supports the company's stated thesis — it is NOT a buy/sell rating or price target. ChartsView is not authorised by the FCA to provide regulated investment advice. Generated 30 Apr 2026.
